Day One Biopharmaceuticals Holding Co LLC (18)
Browse by Contract Category
Contracts
-
Underwriting Agreement, dated June 14, 2022
(Filed With SEC on June 16, 2022)
-
Form of Change in Control and Severance Agreement
(Filed With SEC on March 7, 2022)
-
Description of Registrants Securities
(Filed With SEC on March 7, 2022)
-
License Agreement, dated February 10, 2021, by and between Merck KGaA, Darmstadt, Germany and Day One Biopharmaceuticals, Inc
(Filed With SEC on May 4, 2021)
-
Office Lease, dated February 8, 2020, by and between Kashiwa Fudosan America, Inc. and Day One Therapeutics, Inc
(Filed With SEC on May 4, 2021)
-
Form of Indemnification Agreement with directors and officers
(Filed With SEC on May 4, 2021)
-
Form of Underwriting Agreement
(Filed With SEC on May 24, 2021)
-
Employment Offer Letter, dated May 19, 2020, by and between the Registrant and Dr. Jeremy Bender
(Filed With SEC on May 24, 2021)
-
2021 Employee Stock Purchase Plan and forms of award agreements
(Filed With SEC on May 24, 2021)
-
2021 Equity Incentive Plan and forms of award agreements
(Filed With SEC on May 24, 2021)
-
Form of Common Stock Certificate
(Filed With SEC on May 24, 2021)
-
Form of Plan of Conversion
(Filed With SEC on May 4, 2021)
-
Amended and Restated Investors Rights Agreement, dated February 1, 2021, by and among the Registrant and certain of its stockholders
(Filed With SEC on May 4, 2021)
-
License Agreement for RAF, effective as of December 16, 2019, by and between Sunesis Pharmaceuticals, Inc. and DOT Therapeutics-1, Inc
(Filed With SEC on May 4, 2021)
-
Asset Transfer and License Agreement, effective as of December 16, 2019, by and between DOT Therapeutics-1, Inc. and Millennium Pharmaceuticals, Inc
(Filed With SEC on May 4, 2021)
-
2021 Employee Stock Purchase Plan and forms of award agreements
(Filed With SEC on May 4, 2021)
-
2021 Equity Incentive Plan and forms of award agreements
(Filed With SEC on May 4, 2021)
-
Stock Exchange Agreement, dated May 4, 2021, by and between Day One BioPharmaceuticals Holding Co., LLC and Millennium Pharmaceuticals, Inc
(Filed With SEC on May 4, 2021)
